Italy Blood Glucose Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Italy Blood Glucose Monitoring Market is Segmented Into Type (Self-Monitoring Blood Glucose, And Continuous Glucose Monitoring), Component (Glucometer Devices, Test Strips, Lancets, Sensors, And Durables). The Report Offers the Value (in USD) and Volume (in Units) for the Above Segments.

Italy Blood Glucose Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Italy Blood Glucose Monitoring Market Size

View Global Report
Italy Blood Glucose Monitoring Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 0.70 Billion
Market Size (2030) USD 1.06 Billion
CAGR (2025 - 2030) 8.50 %

Major Players

Italy Blood Glucose Monitoring Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Italy Blood Glucose Monitoring Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Italy Blood Glucose Monitoring Market Analysis

The Italy Blood Glucose Monitoring Market size is estimated at USD 0.70 billion in 2025, and is expected to reach USD 1.06 billion by 2030, at a CAGR of 8.5% during the forecast period (2025-2030).

The rising number of diabetes cases in Italy is fueling the growth of the market for blood glucose monitoring devices in the forecasted period. Diabetes, a chronic disease characterized by high blood sugar levels, has become a significant health concern in Italy, with an increasing number of individuals being diagnosed with the condition. This surge in diabetes cases has created a demand for effective and efficient blood glucose monitoring devices to help individuals manage their condition.

Blood glucose monitoring devices play a crucial role in the management of diabetes by allowing individuals to regularly monitor their blood sugar levels. These devices provide accurate and real-time readings, enabling individuals to make informed decisions about their diet, medication, and lifestyle choices. With the rising prevalence of diabetes in Italy, there is a growing need for these devices to help individuals maintain optimal blood sugar levels and prevent complications associated with the disease.

The market for blood glucose monitoring devices in Italy is expected to witness significant growth in the forecasted period due to several factors. Firstly, the increasing awareness about diabetes and its management among the general population has led to a higher demand for blood glucose monitoring devices. Individuals are becoming more proactive in monitoring their health and are seeking reliable and user-friendly devices to assist them in managing their diabetes effectively.

Additionally, the increasing geriatric population in Italy, who are more susceptible to developing diabetes, has contributed to the growth of the market. As the elderly population continues to grow, there is a higher demand for blood glucose monitoring devices to cater to their specific needs and ensure effective diabetes management.

Furthermore, government initiatives and healthcare policies aimed at promoting diabetes awareness and prevention have also played a significant role in driving the market growth. These initiatives have increased the accessibility and affordability of blood glucose monitoring devices, making them more widely available to individuals with diabetes.

In conclusion, the rising number of diabetes cases in Italy has fueled the growth of the market for blood glucose monitoring devices in the forecasted period. Factors such as increasing awareness, technological advancements, the growing geriatric population, and government initiatives have contributed to the expansion of the market. As the prevalence of diabetes continues to rise, the demand for blood glucose monitoring devices is expected to further increase, creating opportunities for manufacturers

Italy Blood Glucose Monitoring Industry Overview

The blood glucose monitoring market is highly fragmented, with few major manufacturers present in the market. The CGM devices market is dominated by major players like Dexcom, Medtronics, Abbott, and Senseonics. The market for BGM devices comprises more generic players like Roche, LifeScan, Arkray, Ascensia, etc. Technological innovations in the recent past helped companies to strengthen their market presence.

Italy Blood Glucose Monitoring Market Leaders

  1. Roche

  2. Abbott

  3. Dexcom

  4. Medtronics

  5. LifeScan

  6. *Disclaimer: Major Players sorted in no particular order
Italy Blood Glucose Monitoring Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Italy Blood Glucose Monitoring Market News

  • October 2023: Medtronic's Simplera is the most recent continuous glucose monitor (CGM) designed for individuals aged 2 and above who have diabetes. Currently undergoing FDA evaluation for approval in the United States, Simplera is an elegant, disposable device that eliminates the need for fingersticks. In Europe, Medtronic's latest CGM, Simplera, has already received approval.
  • March 2022: DexCom announced the receipt of a CE Mark for its G7 CGM system in Europe, intended for people who have diabetes and are two years and older, including pregnant women. With this approval, the highly popular and best-selling real-time CGM in the world is now more powerful and easier to use with a small, all-in-one wearable and completely redesigned mobile app.

Italy Blood Glucose Monitoring Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Drivers
  • 4.3 Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Self-monitoring blood glucose devices
    • 5.1.1 Glucometer Devices
    • 5.1.2 Test Strips
    • 5.1.3 Lancets
  • 5.2 Continuous blood glucose monitoring devices
    • 5.2.1 Sensors
    • 5.2.2 Durables (Receivers and Transmitters)

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes population
  • 6.2 Type-2 Diabetes population

7. COMPETITIVE LANDSCAPE

  • 7.1 COMPANY PROFILES
    • 7.1.1 Abbott Diabetes Care
    • 7.1.2 Roche Holding AG
    • 7.1.3 LifeScan
    • 7.1.4 Dexcom Inc.
    • 7.1.5 Medtronic PLC
    • 7.1.6 Arkray Inc.
    • 7.1.7 Ascensia Diabetes Care
    • 7.1.8 Agamatrix Inc.
    • 7.1.9 Bionime Corporation
    • 7.1.10 Acon Laboratories Inc.
    • 7.1.11 Trivida Functional Medicine
    • 7.1.12 Senseonics
  • *List Not Exhaustive
  • 7.2 COMPANY SHARE ANALYSIS
    • 7.2.1 Self-monitoring Blood Glucose Devices
    • 7.2.1.1 Abbott Diabetes Care
    • 7.2.1.2 Roche Holding AG
    • 7.2.1.3 LifeScan
    • 7.2.1.4 Others
    • 7.2.2 Continuous Glucose Monitoring Devices
    • 7.2.2.1 Dexcom Inc.
    • 7.2.2.2 Medtronic PLC
    • 7.2.2.3 Abbott Diabetes Care

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Italy Blood Glucose Monitoring Industry Segmentation

Italy Blood Glucose Monitoring Market witnessed USD 0.5 billion in the current year and is anticipated to register a CAGR of over 5% during the forecast period. Italy Blood Glucose Monitoring Market is segmented into Type (Self-monitoring Blood Glucose and Continuous Glucose Monitoring), Component (Glucometer Devices, Test Strips, Lancets, Sensors, and Durables). The report offers the value (in USD million) and volume (in Units million) for the above segments.

Self-monitoring blood glucose devices Glucometer Devices
Test Strips
Lancets
Continuous blood glucose monitoring devices Sensors
Durables (Receivers and Transmitters)
Need A Different Region or Segment?
Customize Now

Italy Blood Glucose Monitoring Market Research FAQs

How big is the Italy Blood Glucose Monitoring Market?

The Italy Blood Glucose Monitoring Market size is expected to reach USD 0.70 billion in 2025 and grow at a CAGR of 8.5% to reach USD 1.06 billion by 2030.

What is the current Italy Blood Glucose Monitoring Market size?

In 2025, the Italy Blood Glucose Monitoring Market size is expected to reach USD 0.70 billion.

Who are the key players in Italy Blood Glucose Monitoring Market?

Roche, Abbott, Dexcom, Medtronics and LifeScan are the major companies operating in the Italy Blood Glucose Monitoring Market.

What years does this Italy Blood Glucose Monitoring Market cover, and what was the market size in 2024?

In 2024, the Italy Blood Glucose Monitoring Market size was estimated at USD 0.64 billion. The report covers the Italy Blood Glucose Monitoring Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Italy Blood Glucose Monitoring Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Italy Blood Glucose Monitoring Industry Report

Statistics for the 2025 Italy Blood Glucose Monitoring market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Italy Blood Glucose Monitoring analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.